Related Experiment Video
Updated: Aug 6, 2025
08:28
Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
3.8K
Smooth muscle tumor of uncertain malignant potential (STUMP): a case-based analysis
Caglar Helvacioglu1, Mustafa Eroğlu2, Cem Yalçınkaya3
1Department of Obstetrics and Gynecology, Maternal-Fetal Unit, University of Health Sciences Umraniye Training and Research Hospital, Istanbul, Türkiye. caglarhel@hotmail.com.
Ginekologia Polska
|March 17, 2023
Summary
Uterine smooth muscle tumors of uncertain malignant potential (STUMP) have a 12% recurrence rate. Fertility-preserving treatment with close follow-up is recommended for STUMP patients due to their relatively young age at diagnosis.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
- Reproductive Medicine
Background:
- Uterine smooth muscle tumors of uncertain malignant potential (STUMP) represent a diagnostic challenge.
- Understanding STUMP behavior and patient outcomes is crucial for appropriate management.
Purpose of the Study:
- To analyze the clinical characteristics and outcomes of patients diagnosed with STUMP.
- To evaluate the recurrence rate and survival associated with STUMP.
Main Methods:
- Retrospective review of 25 patients diagnosed with STUMP between 2005 and 2020.
- Assessment of demographic data, treatment modalities (myomectomy vs. hysterectomy), recurrence, disease-free survival, and overall survival.
Main Results:
- The study included 25 patients with a mean age of 43.2 years.
- A 12% recurrence rate was observed (3 out of 25 patients).
- One patient experienced a fatal outcome due to peritonitis carcinomatosa despite aggressive treatment.
Conclusions:
- STUMP exhibits a recurrence rate of 12%, consistent with existing literature.
- Given the potential for malignant recurrence, fertility-sparing approaches with vigilant monitoring are advisable for STUMP.
- Early diagnosis and tailored management strategies are key for improving STUMP patient outcomes.
